When low-dose HuIFNα treatment, given by nasal spray tid for three days and then once daily for two days, was started in a factory or school immediately after the first case of influenza, an approximately 60% decrease in influenza symptoms was reported in IFNα-treated patients, without adverse events. Here, IFNA1 is linked to influenza.